Association Between Proteinuria and Pregnancy Outcomes in Women With Preterm Pre‐Eclampsia Undergoing Expectant Management: Secondary Analysis of Two Randomised Trials

Amy van Rooyen, Lina Bergman, Henrik Imberg, Denise Sproul, Susan P. Walker, Stephen Tong, Catherine A. Cluver
{"title":"Association Between Proteinuria and Pregnancy Outcomes in Women With Preterm Pre‐Eclampsia Undergoing Expectant Management: Secondary Analysis of Two Randomised Trials","authors":"Amy van Rooyen, Lina Bergman, Henrik Imberg, Denise Sproul, Susan P. Walker, Stephen Tong, Catherine A. Cluver","doi":"10.1111/1471-0528.70335","DOIUrl":null,"url":null,"abstract":"Objective Evaluate whether proteinuria levels, in women undergoing expectant management for pre‐eclampsia, are associated with pregnancy latency and adverse outcomes. Design Secondary analysis of data from two randomised trials. Setting Tygerberg Hospital, Cape Town, South Africa. Population Women undergoing expectant management for pre‐eclampsia diagnosed between 26 and 32 weeks. Methods Latency was analysed using parametric time‐to‐event methods to estimate increases. Composite outcomes were assessed using Poisson regression. Main Outcome Measures Pregnancy latency Composite adverse maternal or perinatal outcomes. Results Two hundred and ninety‐one women were included. Women with < 3 g/24 h had a median prolongation of 15.3 days (interquartile range (IQR) 4.3 to 25.6), compared to 10.0 days (IQR 5.0 to 19.6) with proteinuria between 3 to 5 g/24 h; and 4.9 days (IQR 3.8 to 11.7) for those with ≥ 5 g/24 h. Increasing levels were also associated with increases in subsequent adverse composite maternal outcomes: 8.8% of women with < 3 g/24 h experienced maternal complications, compared to 16.1% with 3 to 5 g/24 h, and 27.9% with ≥ 5 g/24 h. There was no association with composite perinatal adverse outcomes. The sFlt‐1/PIGF ratio performed slightly better in predicting latency (area under the receiver operating characteristic curve (AUC) 0.78 vs. 0.67) but similarly in predicting adverse composite maternal outcomes (AUC 0.67 vs. 0.64). Both had poor performance for predicting composite adverse perinatal outcomes (AUC 0.61 vs. 0.56). Conclusion Levels of proteinuria strongly correlate with pregnancy latency and adverse maternal outcomes, but not perinatal outcomes, in women with pre‐eclampsia undergoing expectant management. They perform similarly to angiogenic markers. Proteinuria levels may confer useful prognostic information to assist clinical decision‐making.","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"150 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJOG: An International Journal of Obstetrics & Gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/1471-0528.70335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective Evaluate whether proteinuria levels, in women undergoing expectant management for pre‐eclampsia, are associated with pregnancy latency and adverse outcomes. Design Secondary analysis of data from two randomised trials. Setting Tygerberg Hospital, Cape Town, South Africa. Population Women undergoing expectant management for pre‐eclampsia diagnosed between 26 and 32 weeks. Methods Latency was analysed using parametric time‐to‐event methods to estimate increases. Composite outcomes were assessed using Poisson regression. Main Outcome Measures Pregnancy latency Composite adverse maternal or perinatal outcomes. Results Two hundred and ninety‐one women were included. Women with < 3 g/24 h had a median prolongation of 15.3 days (interquartile range (IQR) 4.3 to 25.6), compared to 10.0 days (IQR 5.0 to 19.6) with proteinuria between 3 to 5 g/24 h; and 4.9 days (IQR 3.8 to 11.7) for those with ≥ 5 g/24 h. Increasing levels were also associated with increases in subsequent adverse composite maternal outcomes: 8.8% of women with < 3 g/24 h experienced maternal complications, compared to 16.1% with 3 to 5 g/24 h, and 27.9% with ≥ 5 g/24 h. There was no association with composite perinatal adverse outcomes. The sFlt‐1/PIGF ratio performed slightly better in predicting latency (area under the receiver operating characteristic curve (AUC) 0.78 vs. 0.67) but similarly in predicting adverse composite maternal outcomes (AUC 0.67 vs. 0.64). Both had poor performance for predicting composite adverse perinatal outcomes (AUC 0.61 vs. 0.56). Conclusion Levels of proteinuria strongly correlate with pregnancy latency and adverse maternal outcomes, but not perinatal outcomes, in women with pre‐eclampsia undergoing expectant management. They perform similarly to angiogenic markers. Proteinuria levels may confer useful prognostic information to assist clinical decision‐making.
接受准治疗的早产先兆子痫患者蛋白尿与妊娠结局的关系:两项随机试验的二次分析
目的评估孕妇在接受子痫前期治疗时的蛋白尿水平是否与妊娠潜伏期和不良结局相关。设计对两项随机试验的数据进行二次分析。背景:南非开普敦Tygerberg医院。人群26 - 32周诊断为先兆子痫的妇女接受孕妇治疗。方法采用参数时间-事件法分析潜伏期,以估计潜伏期的增加。使用泊松回归评估综合结果。主要结局指标妊娠潜伏期综合不良产妇或围产期结局。结果纳入291名女性。3 g/24 h的女性平均延长15.3天(四分位数范围(IQR) 4.3 - 25.6),而3 - 5 g/24 h的女性平均延长10.0天(IQR 5.0 - 19.6);≥5 g/24 h的孕妇的妊娠期为4.9天(IQR 3.8 - 11.7)。浓度增加还与随后不良综合产妇结局的增加有关:浓度为3 g/24 h的孕妇中有8.8%出现了产妇并发症,而浓度为3 - 5 g/24 h的为16.1%,浓度≥5 g/24 h的为27.9%。与围产期综合不良结局无关。sFlt‐1/PIGF比值在预测潜伏期(受试者工作特征曲线下面积(AUC) 0.78 vs 0.67)方面表现稍好,但在预测不良综合产妇结局方面表现相似(AUC 0.67 vs 0.64)。两者在预测围产期综合不良结局方面的表现都不佳(AUC 0.61 vs 0.56)。结论:在接受预期治疗的先兆子痫患者中,蛋白尿水平与妊娠潜伏期和不良产妇结局密切相关,但与围产期结局无关。它们的作用与血管生成标志物相似。蛋白尿水平可以提供有用的预后信息,以协助临床决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书